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Abstract: Catechins that are found in green tea, especially 
(-)-epigallocatechin-3-gallate (EGCG), have anti-tumor activity. The major 
anti-tumor mechanisms are anti-oxidation, anti-angiogenesis and 
anti-metastasis. Cell migration and invasion abilities are included in 
metastasis. Real-time cell analysis (RTCA) measures cell migration and 
invasion in vitro. In this study, using RTCA we investigated if the cell 
migration and invasion of oral squamous cell carcinomas (OSCCs) of the 
tongue and floor of the mouth, were inhibited by EGCG. We used the human 
SCC-4 and SAS cell lines that are poorly differentiated OSCCs of the tongue, 
and the floor of the mouth HO-1-u-1 cell line. SCC-4 cells demonstrated high 
cell migration and invasion ability compared with SAS and H0-1-u-1 cells. 
EGCG was most effective in inhibiting the migration and invasion of SCC-4 
cells and inhibited OSCC cell invasion more strongly than it inhibited cell 
migration. EGCG inhibited matrix metalloproteinase (MMP)-2, 9 and integrin 
-1, -1 mRNA expression in OSCCs, in particular in SCC-4 cells. We 
therefore demonstrated that EGCG inhibited OSCC cell migration and 
invasion via inhibition of MMP-2, 9 and integrin alpha1, beta1 expression. 
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These results suggest that EGCG might be a suitable agent or lead 
compound for inhibition of OSCC metastasis. 
 
Key words: oral squamous cell carcinoma, migration, invasion, EGCG, 
real-time cell analyzer 
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Introduction  
 
Green tea is a popular beverage in Japan. Tea has attracted attention with 
regard to its potential for preventing cancer since it contains tea catechins 
and polyphenols1). Recently, a tendency for a reduced risk of oral cancer in 
women who consumed green tea was shown2). Catechins are an important 
constituent of green tea and include: (-)-epigallocatechin-3-gallate (EGCG), 
(-)-epigallocatechin, (-)-epicatechin-3-gallate and (-)-epicatechin3). Catechins, 
especially EGCG, show notable bioactivity in green tea extracts, with effects such as 
anti-tumor activity including anti-oxidation and anti-angiogenesis
4-7)
. Moreover, EGCG 
acts at numerous points to regulate metastasis, including effects at the DNA, RNA, and 
protein levels
8)
. 
    Oral squamous cell carcinoma (OSCC) is the most common malignancy 
of the oral cavity and has a high incidence of cervical micrometastases9, 10). 
Distant metastases reduce patient quality of life and affect the clinical 
outcome10, 11). Increased tumor size and microvascular invasion are the most 
independent prognostic factors in predicting the survival of patients with 
OSCC12). Therefore, the presence of metastasis and invasion are the main 
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prognostic factors of patients with OSCCs. 
    Matrix metalloproteinases (MMPs) are a family of zinc-dependent proteinases that 
are strongly related to cancer metastasis, due to their association with extracellular 
matrix (ECM) degradation and cellular migration
13, 14)
. In particular, MMP-2 and 
MMP-9 are highly expressed in OSCC compared with normal oral mucosal 
tissues, and their mRNA and protein levels are further increased upon tumor 
progression15, 16). In addition, it is well established that MMP-2 and MMP-9 
are closely associated with tumor invasion and metastasis in a variety of 
human tumors17-19). In our previous study, we reported that EGCG inhibited 
the mRNA and protein expression and the activity of MMPs in human 
umbilical vein endothelial cells co-cultured with fibroblasts or osteoclasts20, 
21). Moreover, EGCG inhibits carcinoma cell migration and invasion via 
MMP-2 and MMP-922,23). Integrins are transmembrane heterodimeric receptors that 
interact with the extracellular matrix (ECM). Expression of integrins and proteases of 
the MMP and plasminogen activator families is altered in both healing and malignant 
epithelium and is thus thought to be key in the process of re-epithelialization, cell 
migration and tumor invasion
24, 25)
. EGCG also inhibits the activation and expression of 
Integrins
23, 26)
. It is therefore thought that EGCG plays an important role in 
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inhibition of cancer metastasis by inhibition of MMPs and integrins. 
    We previously reported determination of the migration and invasion of 
OSCCs by using the xCELLigence real-time cell analysis (RTCA; Roche 
Applied Science, Mannheim, Germany) system19). This system makes use of 
impedance detection for continuous monitoring of cell viability, migration 
and invasion27). In this study, we used RTCA to investigate EGCG inhibition of 
the migration and invasion of OSCCs of the tongue and floor of the mouth 
and we also investigated the expression of associated MMP or integrin 
mRNA.  
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Materials and Methods   
Cell lines and reagents 
The SCC-4
28)
 and SAS
29)
 cell lines were both established from poorly differentiated 
OSCC in the tongue. HO-1-u-1 was also established from a poorly differentiated OSCC 
in the floor of the mouth
30)
. All of the cell lines were provided by the Health 
Science Research Resources Bank (Osaka, Japan). EGCG was purchased 
from Wako Pure Chemical Industries, Ltd., (Wako; Osaka, Japan). 
 
Cell culture 
SAS and HO-1-u-1 cells were cultured at 37°C under a humidified 5% CO2 
and 95% air atmosphere in 45% Dulbecco's modified Eagle's medium with 
45% Ham's F12 medium (DMEM/F12), 10% fetal calf serum (FBS), 100 U/ml 
penicillin and 100 g/ml streptomycin. SCC-4 cells, which are 
undifferentiated cancer cells, were cultured under the same condition in 
DMEM/F12 with 0.4 μg/ml hydrocortisone, 10% fetal calf serum (FBS), 100 
U/ml penicillin and 100 g/ml streptomycin. The medium of all cells was 
changed every 3 days. 
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Real time cell analysis (RTCA)  
The migration and invasion of OSCCs were analyzed by real time cell 
analysis19, 31). Migration was assessed on an RTCA system CIM-plate 16 
coated with fibronectin (20 mg/ml). SCC-4 cells (1.6 x105) or 3.2 x105 SAS or 
HO-1-u-1 cells were seeded into the upper chamber of individual CIM-Plate 
16s in 100 L medium of the respective cell line without FBS and without or 
with EGCG (10 or 100 M). The upper chamber was then placed on the lower 
chamber of the CIM-Plate 16, which contained growth medium 
supplemented with 10% FBS as an attractant. Invasion was assessed using a 
CIM-plate 16 coated with Matrigel (1: 80) (BD Biosciences, Erembodegem, 
Belgium) and fibronectin (20 mg/ml). SCC-4 cells (1.6 x105) or 3.2 x105 SAS 
or H0-1-u-1 cells were seeded in the upper chamber of individual CIM-Plate 
16s in 100 L of the medium of the respective cell line without FBS and 
without or with EGCG (10, 20 or 100 M). The upper chamber was then 
placed on the lower chamber of the CIM-Plate 16 containing growth medium 
supplemented with 10% FBS as an attractant.  
 
RNA isolation and Quantitative Real-time RT-PCR 
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OSCCs seeded in 6 well plates, grown for 1 week at 37 °C and were treated 
with EGCG (0, 10 and 100 M) for 5 hours. Q-PCR was used to quantify the 
mRNA levels of MMP-2 and 9, and of Integrin 1 and 1 in OSCCs. Total 
RNA was extracted using NucleoSpin RNA II (MACHEREY-NAGEL GmbH 
& Co. KG, Duren, Germany) and reverse transcribed using the PrimeScript 
RT Master Mix from TaKaRa Bio Inc. (Shiga, Japan). The resulting cDNAs 
were amplified using primers designed by ProbeFiber software (Roche). 
Table 1 details the primers used, the Roche Universal ProbeLibrary Probe 
numbers, and the gene accession numbers. Amplification was performed 
with a LightCycler (Roche) using the LightCycler TaqMan Master mix 
(Roche). The PCR reaction parameters were as follows: 95 °C for 10 min, 45 
cycles (except for 18s rRNA amplification (25 cycles)) of 10 sec at 95 °C, 30 sec 
at 60 °C, and 1 sec at 72 °C. Fluorescence data were analyzed with 
LightCycler software (Roche). The mRNA levels were compared to 18s rRNA 
as a standard, and relative expression ratios were obtained19). 
 
Statistical Analysis 
 Data of RTCA were analyzed utilizing the Bonferroni test following one-way 
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analysis of variance (ANOVA). Statistical analysis of PCR was performed 
using the Mann-Whitney U-test. All data were expressed as means ± 
standard error (SE). P values of less than 0.05 were considered significant. 
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Results:  
Figure 1 shows the results of RTCA analysis of the effect of EGCG on cell 
invasion through Matrigel and fibronectin-coated invasion chambers. EGCG 
was added to the upper chamber of the invasion apparatus at a 
concentration of 10 or 100 M. EGCG inhibited the invasion of OSCCs in an 
EGCG concentration dependent manner. After 18 hr incubation, the Cell 
index of SCC-4 cells was 3.66 ± 0.10, 0.17 ± 0.12 and 0.02 ± 0.02 for control, 
10 and 100 M EGCG-treated cells, respectively. EGCG treatment resulted 
in approximately 100% inhibition of cell invasion for up to 18 hours after 
EGCG addition (Fig. 1A). At 48 hours after EGCG addition, the invasion of 
SCC-4 cells was inhibited by 98.7% by 100 M EGCG treatment (p<0.01; 
compared with control and 10 M EGCG) and by 76.3% by 10 M EGCG 
treatment (p<0.01; compared with control) (Fig. 1A). The invasion of SAS 
cells was decreased by 93.2% by 100 M EGCG treatment for 24 hr (p<0.01; 
compared with control and 10 M EGCG) and by 63.4% by 10 M EGCG 
treatment for 48 hr (p<0.01; compared with control) (Fig. 1B). The invasion 
of HO-1-u-1 cells was decreased by 92.7% by 100 M EGCG treatment for 24 
hours (p<0.05; compared with control and 10 M EGCG) and by 57.4% by 10 
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M EGCG treatment for 48 hours (p<0.01; compared with control) (Fig. 1C). 
Figure 2 shows the effect of EGCG on cell migratory responses on a 
fibronectin substrate as analyzed using RTCA. EGCG was added to the 
upper chamber of the migration apparatus at a concentration of 10, 20 or 100 
M. The migration of SCC-4 cells was decreased by 99.9% following 48 hr 
treatment with 100 M EGCG (p<0.01; compared with control and 10 and 20 
M EGCG) and by 55.1% by 10 M EGCG treatment (p<0.01; compared with 
control) (Fig. 2A). The migration of SAS cells decreased by 95.7% following 
48 hr treatment with 100 M EGCG (p<0.01; compared with control and 10 
and 20 M EGCG) and by 16.6% by 10 M EGCG (p<0.01; compared with 
control and 20 and 100 M EGCG) (Fig. 1B). The migration of HO-1-u-1 cells 
was decreased by 93.9% following 48 hours treatment with 100 M EGCG 
(p<0.01; compared with control and 10 and 20 M EGCG) but no significant 
change in migration compared to control was observed following 10 M 
EGCG treatment for 48 hours (Fig. 2C). For SCC-4 cells the effect of EGCG 
on the invasion response was similar to that on the migratory response. 
However, for SAS and HO-1-u-1 cells, EGCG induced a greater decrease in 
cell invasion responses compared with the decrease induced in cell migratory 
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responses, particularly at 10 M EGCG. 
     Figures 3~6 show the mRNA expression of MMPs and Integrins of 
OSCCs after treatment with EGCG for 5 hours. These graphs show the 
control levels as 100%. Treatment of SCC-4 cells with 100 M EGCG induce 
a 52.9% decrease in MMP-2 mRNA levels (p<0.05) compared with control 
(Fig. 3A). However, MMP-2 mRNA levels did not change significantly 
compared to control values in EGCG treated SAS and HO-1-u-1 cells (Fig. 3B, 
C). Treatment of SCC-4 cells with EGCG resulted in a 60.7% (10 M, p<0.05) 
or a 67.0% (100 M, p<0.05) decrease in MMP-9 mRNA levels compared with 
control (Fig. 4A). Treatment of HO-1-u-1 cells with EGCG resulted in a 
43.8% (10 M: p<0.05) or a 55.0 % (100 M: p<0.05) decrease in MMP-9 
mRNA levels compared with control (Fig. 4C). The MMP-9 mRNA levels of 
SAS cells tended to decrease compared with control following EGCG 
treatment (Fig. 4B). EGCG treatment (100 M) of SSC-4 and HO-1-u-1 cells 
decreased Integrin1 mRNA levels to 32.6% (p<0.05) and 45.5% (p<0.05), 
respectively, compared with the control (Fig. 5A and C, respectively). The 
Integrin1 mRNA levels of 100 M EGCG-treated SAS cells tended to 
decrease compared with control (Fig. 5B). EGCG treatment of SCC-4 cells 
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decreased Integrin1 mRNA levels by 58.5% (10 M, p<0.01) or 60.4% (100 
M, p<0.01) compared with control (Fig. 6A). Treatment of SAS and 
HO-1-u-1 cells with 100 M EGCG treatment decreased Integrin1 mRNA 
levels by 64.7% (p<0.05) and 69.8% (p<0.05), respectively, compared with 
control (Fig. 6B and C, respectively). 
    Our previous study showed that the mRNA levels, especially the MMP-9 
and integrin1 mRNA levels, of SCC-4 cells were high compared with the 
levels in SAS and HO-1-u-1 cells. The MMP-9 mRNA levels of SCC-4 cells 
were 4.91 times (p<0.01) and 1.90 times (p<0.05) higher than the levels in 
HO-1-u-1 and SAS cells, respectively. The Integrin1 mRNA levels of SCC-4 
cells were 13.8 times (p<0.05) higher than the levels in HO-1-u-1 cells. On 
the other hand, there was no significant difference in the Integrin1 and 
MMP-2 mRNA levels between SCC-4, SAS and HO-1-u-1 cells19).  
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Discussion  
We demonstrated, using RTCA analysis, that EGCG inhibited the 
migratory and invasion responses of poorly differentiated OSCCs and that 
these responses were associated with MMP-9 and Integrin1 in real time. 
The use of RTCA facilitated capture of the effect of EGCG on the 
characteristic of three kinds of OSCCs. 
A frequent problem with using EGCG as an anticancer agent is a low 
blood EGCG concentration. Lee et al. have reported that locally high 
concentrations (Cmax = 131.0 to 2.2 M) of tea polyphenols can be achieved by 
holding green tea leaves in the oral cavity32).  Since we demonstrated using 
RTCA that 100 M EGCG clearly inhibited cellular migratory and invasion 
responses, these results demonstrate that EGCG has the potential to be 
effective against cancer cells. However, it will be difficult to immediately use 
EGCG for clinical treatment because the medication method and the dosage 
of EGCG need to be established. 
MMP-2 and MMP-9 are important targets for the prevention of cancer 
migration and invasion33). This is because cancer cell-matrix interaction is a 
critical step in the promotion of cell migration34, 35) and proteolytic 
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degradation of the extracellular matrix (ECM) is a crucial event during 
tumor invasion and metastasis. This role of MMPs explains why the invasion 
and migration of OSCCs were inhibited by down-regulation of the production 
of MMP-2 and MMP-9 by EGCG. In our previous study, by using the broad 
spectrum matrix metalloprotease inhibitor Marimastat, we demonstrated 
that MMPs are associated with the invasion and metastasis of OSSCs19). 
Moreover, it is known that EGCG inhibits the mRNA expression and activity 
of MMP-2 and MMP-920, 21). SCC-4 cells expressed much higher levels of 
MMP than SAS and HO-1-u-1 cells. It is therefore interesting that the 
MMP-2 and MMP-9 mRNA levels and the tumor invasion and migration of 
SCC-4 cells were more strongly inhibited by EGCG than those of SAS and 
HO-1-u-1 cells. The difference in the inhibitory effect of EGCG on the 
different cells was particularly strong when the effect of 10 M EGCG 
treatment on tumor invasion and migration was assayed. Moreover, in this 
study, EGCG inhibited the invasion of OSCCs more effectively than it 
inhibited their migration. The stronger effect of EGCG on cell invasion as 
determined using RTCA may be due to the fact that MMP-2 and MMP-9 
appear to be necessary for degradation of the Matrigel during tumor invasion. 
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No effect of EGCG on MMP-2 mRNA expression in SAS and HO-1-u-1 cells 
was observed. However, EGCG has been previously shown to affect MMP 
activity, in particular MMP-2 activity, both directly and indirectly, at 
relatively low doses (10-20 M) 21, 22). 
The  and subunits of integrins contribute to the formation of the 
ligand binding pocket. However, the  subunit is likely to play an important 
role in determining binding selectivity since integrin heterodimers often 
share a common  subunit but have a distinct  chain and bind different 
ligands36). Coordinated cellular responses to ECM attachment that are 
mediated by integrins have been shown to induce tumor cell metastasis37). 
Sen T et al. have shown that integrin-mediated signaling is necessary for 
EGF-mediated responses and that integrins collaborate with EGF in the 
phosphorylation and enhancement of the activation of tyrosine kinases such 
as FAK and ERK38). EGCG inhibits even the co-operative responses of 
integrin and growth factor receptors38). In this study, we showed that EGCG 
reduced integrin1 and integrin1 mRNA expression in OSCCs. 
In summary, using RTCA technology we clearly showed EGCG 
inhibition of the migratory and invasion responses of poorly differentiated 
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OSCCs in real time. Our results suggest that EGCG might be a suitable 
agent or lead compound for inhibition of the metastasis of OSCCs via 
inhibition of MMPs and integrins. 
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Table and Figure Legends 
Table 1. Nucleotide sequences of the primers used for PCR  
 
 
Fig. 1.  
Invasion of SCC-4 (A), SAS (B) and HO-1-u-1 (C) cell lines through Matrigel 
and fibronectin was analyzed using RTCA. Cells were re-suspended in their 
respective growth medium and seeded into the wells of a CIM-Plate 16 
(SCC-4; 1.6 x 105 /well, SAS and HO-1-u-1; 3.2 x 105 /well) of the RTCA 
instrument. Cells were allowed to migrate in the absence (Control; blue line) 
or presence of EGCG (10 M; red line or 100 M; green line, added to the 
upper compartment of each well). Changes in impedance resulting from cells 
that had migrated to the bottom side of the membranes were recorded every 
15 min and were monitored for a total of 48 h. Data are presented as mean 
values ± S.E.M. of wells (Cell index (CI) values were: A; Control=10, 10 M=7 
and 100 M=7, B; Control=10, 10 M=6 and 100 M=6, C; Control=10, 10 
M=5 and 100 M=5). *; P < 0.05 vs. control, **; P < 0.01 vs. control, #; P < 
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0.05 vs. 10 M EGCG, ##; P < 0.01 vs. 10 M EGCG. 
 
 
Fig. 2.  
The migration of SCC-4 (A), SAS (B) and HO-1-u-1 (C) cell lines over 
fibronectin was analyzed using RTCA. Cells were re-suspended in their 
respective growth medium and seeded into the wells of a CIM-Plate 16 
(SCC-4; 1.6 x 105 /well, SAS and HO-1-u-1; 3.2 x 105 /well) of the RTCA 
instrument. Cells were allowed to migrate in the absence (Control; blue line) 
or presence of EGCG (10 M; red line, 20 M; green line or 100 M; purple 
line, added to the upper compartment of each well). Changes in impedance 
resulting from cells that had migrated to the bottom side of the membranes 
were recorded every 15 min and were monitored for a total of 48 h. Data are 
presented as mean values ± S.E.M. of wells (Cell index (CI) values were: A; 
Control=10, 10 M=7, 20 M=7 and 100 M=7, B; Control=10, 10 M=6, 20 
M=7 and 100 M=6, C; Control=10, 10 M=5, 20 M=7 and 100 M=5). *; P 
< 0.05 vs. control, **; P < 0.01 vs. control, #; P < 0.05 vs. 10 M EGCG, ##; P < 
0.01 vs. 10 M EGCG, &; P < 0.05 vs. 20 M EGCG, &&; P < 0.01 vs. 20 M 
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EGCG. 
 
 
Fig. 3.  
MMP-2 mRNA expression in SCC-4 (A), SAS (B) and HO-1-u-1 (C) cell lines, 
relative to their respective control, was determined using the quantitative 
real-time polymerase chain reaction. Data are shown as means ± S.E.M. (A; 
Control=6, 10 M=6 and 100 M=6, B; Control=4, 10 M=6 and 100 M=4, C; 
Control=4, 10 M=4 and 100 M=4). *; P < 0.05 vs. Control.  
 
 
Fig. 4. 
MMP-9 mRNA expression of SCC-4 (A), SAS (B) and HO-1-u-1 (C) cell lines, 
relative to their respective control, was determined using the quantitative 
real-time polymerase chain reaction. Data are shown as means ± S.E.M. (A; 
Control=6, 10 M=6 and 100 M=6, B; Control=4, 10 M=4 and 100 M=4, C; 
Control=4, 10 M=4 and 100 M=4). *; P < 0.05 vs. Control. 
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Fig. 5.  
Integrin1 mRNA expression of SCC-4 (A), SAS (B) and HO-1-u-1 (C) cells 
lines, relative to their respective control, was determined using the 
quantitative real-time polymerase chain reaction. Data are shown as means 
± S.E.M. (A; Control=6, 10 M=6 and 100 M=6, B; Control=4, 10 M=4 and 
100 M=4, C; Control=4, 10 M=4 and 100 M=4). *; P < 0.05 vs. Control. 
 
 
Fig. 6.  
 Integrin1 mRNA expression of SCC-4 (A), SAS (B) and HO-1-u-1 (C) cells, 
relative to their respective control, was determined using the quantitative 
real-time polymerase chain reaction. Data are shown as means ± S.E.M. (A; 
Control=6, 10 M=6 and 100 M=6, B; Control=4, 10 M=4 and 100 M=4, C; 
Control=4, 10 M=4 and 100 M=4). *; P < 0.05 vs. Control, **; P < 0.01 vs. 
Control. 
Table 1
Gene Sequence Accession number Probe number
MMP-2
Sense primer 5'-gagggggcaggtcatgtag-3'
AY738117.1 #58
Antisense primer 5'-ggctggatgagatcttgctg-3'
MMP-9
Sense primer 5'-gaaccaatctcaccgacagg-3'
NM_004994.2 #6
Antisense primer 5'-gccacccgagtgtaaccata-3'
Integrin a1
Sense primer 5'-aattggctctagtcaccattgtt-3'
NM_181501.1 #14
Antisense primer 5'-caaatgaagctgctgactggt-3'
Integrin b1
Sense primer 5'-cgatgccatcatgcaagt-3'
NM_002211.3 #65
Antisense primer 5'-acaccagcagccgtgtaac-3'
18s
Sense primer 5'-gcaattattccccatgaacg-3'
X03205.1 #48
Antisense primer 5'-gggacttaatcaacgcaagc-3'
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